Articles

PharmaCompass: Nitrosamine impurities can be avoided by careful selection of raw materials and processing conditions.

Since 2018, several drug products have been found to contain unacceptable levels of nitrosamines. In this PharmaCompass article, Societal^™ CDMO experts address the steps pharmaceutical companies need to take to assess and mitigate risks from nitrosamine impurities.